BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 26351698)

  • 21. Host Gene Expression Is Regulated by Two Types of Noncoding RNAs Transcribed from the Epstein-Barr Virus BamHI A Rightward Transcript Region.
    Marquitz AR; Mathur A; Edwards RH; Raab-Traub N
    J Virol; 2015 Nov; 89(22):11256-68. PubMed ID: 26311882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The novel long noncoding RNA linc00467 promotes cell survival but is down-regulated by N-Myc.
    Atmadibrata B; Liu PY; Sokolowski N; Zhang L; Wong M; Tee AE; Marshall GM; Liu T
    PLoS One; 2014; 9(2):e88112. PubMed ID: 24586304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells.
    Sampson VB; Rong NH; Han J; Yang Q; Aris V; Soteropoulos P; Petrelli NJ; Dunn SP; Krueger LJ
    Cancer Res; 2007 Oct; 67(20):9762-70. PubMed ID: 17942906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MINCR: A long non-coding RNA shared between cancer and neurodegeneration.
    Pandini C; Garofalo M; Rey F; Garau J; Zucca S; Sproviero D; Bordoni M; Berzero G; Davin A; Poloni TE; Pansarasa O; Carelli S; Gagliardi S; Cereda C
    Genomics; 2021 Nov; 113(6):4039-4051. PubMed ID: 34662711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The lncRNA-MYC regulatory network in cancer.
    Deng K; Guo X; Wang H; Xia J
    Tumour Biol; 2014 Oct; 35(10):9497-503. PubMed ID: 25139102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation.
    De Falco G; Ambrosio MR; Fuligni F; Onnis A; Bellan C; Rocca BJ; Navari M; Etebari M; Mundo L; Gazaneo S; Facchetti F; Pileri SA; Leoncini L; Piccaluga PP
    BMC Cancer; 2015 Oct; 15():668. PubMed ID: 26453442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA THOR acts as a retinoblastoma promoter through enhancing the combination of c-myc mRNA and IGF2BP1 protein.
    Shang Y
    Biomed Pharmacother; 2018 Oct; 106():1243-1249. PubMed ID: 30119193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long noncoding RNA EMS connects c-Myc to cell cycle control and tumorigenesis.
    Wang C; Yang Y; Zhang G; Li J; Wu X; Ma X; Shan G; Mei Y
    Proc Natl Acad Sci U S A; 2019 Jul; 116(29):14620-14629. PubMed ID: 31262817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. c-Myc targeted regulators of cell metabolism in a transgenic mouse model of papillary lung adenocarcinoma.
    Ciribilli Y; Singh P; Inga A; Borlak J
    Oncotarget; 2016 Oct; 7(40):65514-65539. PubMed ID: 27602772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MYC Immunohistochemistry to Identify MYC-Driven B-Cell Lymphomas in Clinical Practice.
    Kluk MJ; Ho C; Yu H; Chen BJ; Neuberg DS; Dal Cin P; Woda BA; Pinkus GS; Rodig SJ
    Am J Clin Pathol; 2016 Feb; 145(2):166-79. PubMed ID: 26834124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis.
    Sabò A; Kress TR; Pelizzola M; de Pretis S; Gorski MM; Tesi A; Morelli MJ; Bora P; Doni M; Verrecchia A; Tonelli C; Fagà G; Bianchi V; Ronchi A; Low D; Müller H; Guccione E; Campaner S; Amati B
    Nature; 2014 Jul; 511(7510):488-492. PubMed ID: 25043028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The long non-coding RNA PARROT is an upstream regulator of c-Myc and affects proliferation and translation.
    Vučićević D; Gehre M; Dhamija S; Friis-Hansen L; Meierhofer D; Sauer S; Ørom UA
    Oncotarget; 2016 Jun; 7(23):33934-47. PubMed ID: 27129154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A c-Myc regulatory subnetwork from human transposable element sequences.
    Wang J; Bowen NJ; Mariño-Ramírez L; Jordan IK
    Mol Biosyst; 2009 Dec; 5(12):1831-9. PubMed ID: 19763338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myc suppression of Nfkb2 accelerates lymphomagenesis.
    Keller U; Huber J; Nilsson JA; Fallahi M; Hall MA; Peschel C; Cleveland JL
    BMC Cancer; 2010 Jul; 10():348. PubMed ID: 20598117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decitabine represses translocated MYC oncogene in Burkitt lymphoma.
    Guan H; Xie L; Klapproth K; Weitzer CD; Wirth T; Ushmorov A
    J Pathol; 2013 Apr; 229(5):775-83. PubMed ID: 23341364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iron specific growth inhibition of Burkitt's lymphoma cells in vitro, associated with a decrease in translocated c-myc expression.
    Habel ME; Lemieux R; Jung D
    J Cell Physiol; 2005 Apr; 203(1):277-85. PubMed ID: 15468060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review on the role of MYC-induced long non-coding RNA in human disorders.
    Taheri M; Askari A; Hussen BM; Eghbali A; Ghafouri-Fard S
    Pathol Res Pract; 2023 Aug; 248():154568. PubMed ID: 37285737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and Significance of LncRNA-MINCR and CDK2 mRNA in Primary Hepatocellular Carcinoma.
    Lian J; Zhang X; Lu Y; Hao S; Zhang Z; Yang Y
    Comb Chem High Throughput Screen; 2019; 22(3):201-206. PubMed ID: 30947664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA ontology: inferring lncRNA functions based on chromatin states and expression patterns.
    Li Y; Chen H; Pan T; Jiang C; Zhao Z; Wang Z; Zhang J; Xu J; Li X
    Oncotarget; 2015 Nov; 6(37):39793-805. PubMed ID: 26485761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Next-generation sequencing reveals novel differentially regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA in pancreatic cancer.
    Müller S; Raulefs S; Bruns P; Afonso-Grunz F; Plötner A; Thermann R; Jäger C; Schlitter AM; Kong B; Regel I; Roth WK; Rotter B; Hoffmeier K; Kahl G; Koch I; Theis FJ; Kleeff J; Winter P; Michalski CW
    Mol Cancer; 2015 Apr; 14():94. PubMed ID: 25910082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.